Would a pulmonary embolism (PE) causing cor pulmonale be classified as a massive or submassive PE?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Classification of Pulmonary Embolism with Cor Pulmonale

A pulmonary embolism causing cor pulmonale should be classified as submassive PE, not massive PE, according to established guidelines. 1

Understanding PE Classification

Pulmonary embolism is classified into three main categories based on hemodynamic status and evidence of right ventricular dysfunction:

  • Massive PE: Defined as acute PE with sustained hypotension (systolic blood pressure <90 mmHg for at least 15 minutes or requiring inotropic support), pulselessness, or persistent profound bradycardia (heart rate <40 bpm with signs of shock) 1

  • Submassive PE: Defined as acute PE without systemic hypotension but with evidence of right ventricular dysfunction (including cor pulmonale) 1

  • Non-massive PE: Acute PE without hypotension or evidence of right ventricular dysfunction 1

Cor Pulmonale in PE Classification

  • Cor pulmonale (right ventricular enlargement and dysfunction due to pulmonary hypertension) in the setting of PE without hypotension is specifically classified as submassive PE 1

  • The European Society of Cardiology guidelines explicitly state that "evidence of acute cor pulmonale coinciding with a high clinical suspicion in patients without major previous cardiac or respiratory disease" is sufficient for diagnosis of submassive PE 1

  • The presence of right ventricular hypokinesis or dysfunction (which occurs in cor pulmonale) is the defining feature of submassive PE 1

Clinical Implications of Classification

  • Submassive PE with cor pulmonale carries significant prognostic implications, with worse outcomes compared to non-massive PE without right ventricular dysfunction 1

  • Early and late mortality is significantly higher in patients with moderate to severe right ventricular dysfunction assessed by echocardiography in confirmed PE 1

  • The classification impacts treatment decisions, particularly regarding thrombolytic therapy 1

Treatment Considerations Based on Classification

  • For massive PE: Thrombolytic therapy is indicated unless absolutely contraindicated 1

  • For submassive PE with cor pulmonale: Thrombolytic therapy may be considered in the absence of contraindications, though this remains somewhat controversial 1

  • Recent research suggests catheter-directed thrombolysis may reduce mortality in submassive PE with acute cor pulmonale compared to anticoagulation alone 2

  • The use of thrombolytic therapy in patients with submassive PE (RV dysfunction/cor pulmonale) remains debated, with some studies showing benefit and others showing increased bleeding risk without mortality benefit 3, 4

Diagnostic Approach

  • Echocardiography is particularly useful for identifying right ventricular dysfunction and cor pulmonale in suspected PE 1

  • Decreased collapsibility of the inferior vena cava (less than 40% inspiratory change) is reported in 82% of patients with clinically important PE and is a sign that improves with treatment 1

  • CT measurements of right ventricular dilation (RV/LV ratio >0.9) can also help identify submassive PE 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Thrombolysis is not warranted in submassive pulmonary embolism: a systematic review and meta-analysis.

Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.